Company / R&D per Share
Bruker R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$2.61
FY2025
5-year range
$1.45 / $2.61
FY2021-FY2025
Trend
+0.5%
vs FY2024
Sector context
#34 of 103
Health Care
What the data says
At $2.61, Bruker's r&d per share ranks #34 of 103 in the Health Care sector. R&D per Share has increased for 9 consecutive years, from $0.89 in FY2016 to $2.61 in FY2025.
Based on SEC 10-K filings.
2.61 in FY2025 with a 5-year CAGR of +15.2%.
Improved from $2.01 to $2.61 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +18.5%
- 5-Year CAGR
- +15.2%
- 10-Year CAGR
- -
Sector benchmark
#34 of 103 in Health CareTop 33% of 103This company $2.61 Sector average $2.13
▼
+22.2% above sector average
Key checks
Key Insights
- Bruker's r&d per share has grown for 9 consecutive years.
- In FY2025, r&d per share increased 0.5% year-over-year.
- Ranks #34 out of 103 companies in the Health Care sector.
- Lowest r&d per share in the period was in FY2016.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.61 | +0.5% |
| FY2024 | $2.59 | +29.3% |
| FY2023 | $2.01 | +28.1% |
| FY2022 | $1.56 | +7.7% |
| FY2021 | $1.45 | +13.1% |
| FY2020 | $1.28 | +7.2% |
| FY2019 | $1.20 | +7.7% |
| FY2018 | $1.11 | +10.0% |
| FY2017 | $1.01 | +13.0% |
| FY2016 | $0.89 | +3.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026